UK markets closed
NIKKEI 225
38,837.46 -85.54 (-0.22%) HANG SENG
18,444.11 +41.11 (+0.22%) CRUDE OIL
73.32 -0.90 (-1.21%) GOLD FUTURES
2,346.50 -22.80 (-0.96%) DOW
38,631.45 +60.42 (+0.16%) Bitcoin GBP
55,178.13 +1,091.62 (+2.02%)
ACADIA Pharmaceuticals Inc. (DR6.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:00AM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 2.33B |
| Enterprise value | 1.95B |
| Trailing P/E | N/A |
| Forward P/E | 31.35 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.05 |
| Price/book (mrq) | 5.35 |
| Enterprise value/revenue | 2.60 |
| Enterprise value/EBITDA | 348.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.42 |
| 52-week change 3 | -37.61% |
| S&P500 52-week change 3 | 23.33% |
| 52-week high 3 | 29.40 |
| 52-week low 3 | 13.39 |
| 50-day moving average 3 | 15.36 |
| 200-day moving average 3 | 20.96 |
Share statistics
| Avg vol (3-month) 3 | 4 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 165.22M |
| Implied shares outstanding 6 | 167.96M |
| Float 8 | 107.62M |
| % held by insiders 1 | 0.51% |
| % held by institutions 1 | 100.90% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -0.21% |
| Operating margin (ttm) | 7.39% |
Management effectiveness
| Return on assets (ttm) | -0.38% |
| Return on equity (ttm) | -0.41% |
Income statement
| Revenue (ttm) | 813.81M |
| Revenue per share (ttm) | 4.95 |
| Quarterly revenue growth (yoy) | 73.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 6.07M |
| Net income avi to common (ttm) | -1.71M |
| Diluted EPS (ttm) | 0.00 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 470.52M |
| Total cash per share (mrq) | 2.85 |
| Total debt (mrq) | 59.64M |
| Total debt/equity (mrq) | 12.85% |
| Current ratio (mrq) | 2.04 |
| Book value per share (mrq) | 2.81 |
Cash flow statement
| Operating cash flow (ttm) | 63.71M |
| Levered free cash flow (ttm) | 34.42M |
© 2024 Yahoo. All rights reserved.